CD8A and neoplasm: A marked increase in CD8+ T cell infiltration into the tumor microenvironment was also observed during the DAC treatment; considering that a high density of CD8+ cytotoxic T cells is associated with prolonged disease-free survival, low-dose DAC was found to inhibit tumor growth by increasing CD8+ T cell infiltration and T cell effector function in vivo.